Search results
CAR-T for lupus: the ‘tip of the iceberg’ for cell therapy in autoimmune disease
BioPharma Dive via Yahoo Finance· 5 months agoSince a landmark paper in 2022, drugmakers have begun nearly a dozen trials of cell therapies for...
CAR T-Cell Therapies Under FDA Watch on Reports of Malignancies
Zacks via Yahoo Finance· 7 months agoThe FDA has undertaken an investigation of T-cell malignancies in patients undergoing CAR T-cell...
FDA investigating cancer risk linked to CAR-T cell therapy
BioPharma Dive via Yahoo Finance· 7 months agoThe Food and Drug Adminsitration is investigating whether CAR-T cell therapies like Novartis’...
FDA warns of secondary cancer risk tied to CAR-T therapies that treat cancer
CNN via Yahoo News· 5 months agoThe US Food and Drug Administration has issued a new warning about the possible risk of secondary...
Bristol Myers (BMY), TSVT CAR T-Cell Therapy to Face FDA's ODAC
Zacks via Yahoo Finance· 4 months agoBristol Myers (BMY) and its partner TSVT announce that the FDA's ODAC will meet in March to review...
CARsgen’s CAR T MM therapy shows early signs of efficacy in Phase I trial
Clinical Trials Arena via Yahoo Finance· 4 days agoShanghai based-biotech company CARsgen Therapeutics has announced that its CAR T cell candidate...
Eyes On Novartis, Gilead, Bristol Myers As FDA Weighs Risks Vs. Benefits Of Approved CAR T-Cell...
Benzinga via Yahoo Finance· 7 months agoTuesday, the FDA said it received reports of patients developing T-cell malignancies, including...
FDA says cancer treatment CAR-T therapy may cause cancer itself
Newsy via AOL· 5 months agoGrowing bacteria to create CAR-T therapy The Food and Drug Administration will require companies...
FDA investigating risk of secondary cancers after CAR-T therapy to treat cancer
CNN via Yahoo News· 7 months agoThe US Food and Drug Administration has launched an investigation into certain treatments for cancer...
FDA orders new cancer warnings for CAR-T therapies
BioPharma Dive via Yahoo Finance· 5 months agoThe agency later modified its warning for Gilead's Tecartus, tweaking the label's language to reflect the fact that none of T cell malignancies in...